Researchers believe that in their revised 4-factor model to predict patient outcomes in chronic lymphocytic leukemia (CLL), CD49d tops lactate dehydrogenase. Many signs point to CD49d—a VLA-4 integrin ...
Monoclonal gammopathy subtypes, especially IgM-MG, define distinct clinical subsets in CLL, impacting therapeutic outcomes significantly. IgM-MG is linked to poorer prognostic indicators, including ...
A total of 158 patients with a primary diagnosis of CLL admitted to West China Hospital of Sichuan University from November 2019 to December 2022 were selected. The clinical characteristics, ...
Chronic lymphocytic leukemia (CLL) is characterized by secondary immunodeficiency, yet the extent to which global disease-associated immune dysregulation impairs the ability to generate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results